Literature DB >> 30047287

Determinants of suboptimal adherence and elevated HIV viral load in pregnant women already on antiretroviral therapy when entering antenatal care in Cape Town, South Africa.

Kirsty Brittain1,2, Robert H Remien3, Claude A Mellins3, Tamsin K Phillips1,2, Allison Zerbe4, Elaine J Abrams4,5, Landon Myer1,2.   

Abstract

Across sub-Saharan Africa, prevention of mother-to-child transmission services are encountering increasing numbers of women already established on antiretroviral therapy (ART) when entering antenatal care. However, there are few data examining ART adherence and HIV viral load in this group. We used multivariable logistic regression models to examine self-reported suboptimal adherence (defined as missed ART doses on ≥2 days during the preceding 30 days), elevated viral load (≥1000 copies/mL), and factors associated with each among women entering antenatal care on ART. Participants were recruited from one primary care clinic in Gugulethu, Cape Town, as part of a larger study of HIV-positive pregnant and postpartum women. Among 482 pregnant women established on ART and enrolled between May 2013 and June 2014 (median age: 31 years; median duration of ART use: 3 years), 15% reported suboptimal adherence and 12% had elevated viral load. After adjustment for age, suboptimal adherence was significantly more common among women who were not married/cohabiting and women who reported a higher level of concern about taking ART; a higher level of adherence self-efficacy was associated with a reduced odds of suboptimal adherence. In a multivariable model, elevated viral load was significantly associated with previous discontinuation of ART, a higher level of concern about taking ART, and report of an unintended pregnancy. Suboptimal adherence and elevated viral load are common among women entering antenatal care already on ART. Our findings highlight specific beliefs and concerns about ART use during pregnancy that should be addressed in counselling messaging, and suggest that family planning should be more effectively integrated into HIV care. Including adherence and viral load monitoring as part of pregnancy planning for women on ART may be important to achieve safer conception and promote healthy pregnancies.

Entities:  

Keywords:  Adherence; HIV viral load; South Africa; antiretroviral therapy; pregnancy

Mesh:

Substances:

Year:  2018        PMID: 30047287      PMCID: PMC6299265          DOI: 10.1080/09540121.2018.1503637

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  22 in total

Review 1.  Child development: risk factors for adverse outcomes in developing countries.

Authors:  Susan P Walker; Theodore D Wachs; Julie Meeks Gardner; Betsy Lozoff; Gail A Wasserman; Ernesto Pollitt; Julie A Carter
Journal:  Lancet       Date:  2007-01-13       Impact factor: 79.321

2.  Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa.

Authors:  Landon Myer; Tamsin Phillips; Victoria Manuelli; James McIntyre; Linda-Gail Bekker; Elaine J Abrams
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-26       Impact factor: 3.731

3.  Personal HIV knowledge, appointment adherence and HIV outcomes.

Authors:  Deborah Jones; Ryan Cook; Allan Rodriguez; Drenna Waldrop-Valverde
Journal:  AIDS Behav       Date:  2013-01

4.  Correlates of adherence to combination antiretroviral therapy among members of HIV-positive mixed status couples.

Authors:  G J Wagner; R H Remien; A Carballo-Diéguez; C Dolezal
Journal:  AIDS Care       Date:  2002-02

5.  HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa.

Authors:  S C Kalichman; L C Simbayi
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

6.  Correlates of HIV antiretroviral adherence in persons with serious mental illness.

Authors:  G J Wagner; D E Kanouse; P Koegel; G Sullivan
Journal:  AIDS Care       Date:  2004-05

7.  Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence.

Authors:  Jeffrey S Gonzalez; Frank J Penedo; Maria M Llabre; Ron E Durán; Michael H Antoni; Neil Schneiderman; Rob Horne
Journal:  Ann Behav Med       Date:  2007-08

8.  The HIV epidemic and sexual and reproductive health policy integration: views of South African policymakers.

Authors:  Diane Cooper; Joanne E Mantell; Jennifer Moodley; Sumaya Mall
Journal:  BMC Public Health       Date:  2015-03-04       Impact factor: 3.295

9.  Towards comprehensive women's healthcare in sub-Saharan Africa: addressing intersections between HIV, reproductive and maternal health.

Authors:  Tamil Kendall; Till Bärnighausen; Wafaie W Fawzi; Ana Langer
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

10.  Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa.

Authors:  Landon Myer; Tamsin K Phillips; Nei-Yuan Hsiao; Allison Zerbe; Gregory Petro; Linda-Gail Bekker; James A McIntyre; Elaine J Abrams
Journal:  J Int AIDS Soc       Date:  2015-07-06       Impact factor: 5.396

View more
  11 in total

1.  Female adherence self-efficacy before and after couple HIV testing and counseling within Malawi's Option B+ program.

Authors:  Austin Wesevich; Mina C Hosseinipour; Carol E Golin; Nuala McGrath; Mercy Tsidya; Limbikani Chimndozi; Nivedita Bhushan; Irving Hoffman; William C Miller; Nora E Rosenberg
Journal:  AIDS Care       Date:  2019-06-25

2.  Fertility Intentions and Clinical Care Attendance Among Women Living with HIV in South Africa.

Authors:  Katherine B Rucinski; Sheree R Schwartz; Kimberly A Powers; Brian W Pence; Benjamin H Chi; Vivian Black; Helen Rees; Audrey E Pettifor
Journal:  AIDS Behav       Date:  2020-06

3.  START (Supporting Treatment Adherence Readiness through Training) Improves Both HIV Antiretroviral Adherence and Viral Reduction, and is Cost Effective: Results of a Multi-site Randomized Controlled Trial.

Authors:  Glenn J Wagner; Risa Hoffman; Sebastian Linnemayr; Stefan Schneider; Daniel Ramirez; Kyle Gordon; Rachana Seelam; Bonnie Ghosh-Dastidar
Journal:  AIDS Behav       Date:  2021-04-02

Review 4.  Necessity and concerns beliefs and HIV medication adherence: a systematic review.

Authors:  Luke D Mitzel; Peter A Vanable
Journal:  J Behav Med       Date:  2019-08-08

5.  Long-term effects of unintended pregnancy on antiretroviral therapy outcomes among South African women living with HIV.

Authors:  Kirsty Brittain; Tamsin K Phillips; Allison Zerbe; Elaine J Abrams; Landon Myer
Journal:  AIDS       Date:  2019-04-01       Impact factor: 4.177

6.  Effects of individual and neighborhood socioeconomic status on antiretroviral therapy adherence: The role of adherence self-efficacy.

Authors:  Yanping Jiang; Xiaoming Li; Hyunsan Cho; Monique J Brown; Shan Qiao; Mohammad R Haider
Journal:  J Health Psychol       Date:  2019-08-16

Review 7.  Exploring linkages between drought and HIV treatment adherence in Africa: a systematic review.

Authors:  Kingsley Stephen Orievulu; Sonja Ayeb-Karlsson; Sthembile Ngema; Kathy Baisley; Frank Tanser; Nothando Ngwenya; Janet Seeley; Willem Hanekom; Kobus Herbst; Dominic Kniveton; Collins C Iwuji
Journal:  Lancet Planet Health       Date:  2022-04

8.  The prevalence of unintended pregnancy and its association with HIV status among pregnant women in South Africa, a national antenatal survey, 2019.

Authors:  Selamawit Woldesenbet; Tendesayi Kufa; Carl Lombard; Samuel Manda; Diane Morof; Mireille Cheyip; Kassahun Ayalew; Adrian Puren
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

9.  Predictors of low antiretroviral adherence at an urban South African clinic: A mixed-methods study.

Authors:  Connor P Bondarchuk; Nwabisa Mlandu; Tasneem Adams; Elma de Vries
Journal:  South Afr J HIV Med       Date:  2022-02-10       Impact factor: 2.744

10.  Prevalence and predictors for unintended pregnancy among HIV-infected pregnant women in Lira, Northern Uganda: a cross-sectional study.

Authors:  Agnes Napyo; Victoria Nankabirwa; David Mukunya; Josephine Tumuhamye; Grace Ndeezi; Anna Agnes Ojok Arach; Beatrice Odongkara; Paul Waako; Thorkild Tylleskär; James K Tumwine
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.